Last updated on March 2019

Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast Cancer


Brief description of study

The purpose of this study is to evaluate the safety and efficacy of the study drug abemaciclib in participants with high risk, node positive, early stage, hormone receptor positive (HR+), human epidermal receptor 2 negative (HER2-), breast cancer.

Clinical Study Identifier: NCT03155997

Contact Investigators or Research Sites near you

Start Over

Yasuhiro Yanagita

Gunma Prefectural Cancer Center
Ohta, Japan

Seigo Nakamura

Showa University Hospital
Shinagawa-ku, Japan
3.33miles

Yoshinori Ito

The Cancer Institute Hospital of JFCR
Koto-ku, Japan
6.72miles

Kenji Tamura

National Cancer Center Hospital
Chuo-Ku, Japan
7.76miles

Atsushi Yoshida

St. Lukes International Hospital
Chuo-Ku, Japan
8.09miles

Takashi Ishikawa

Tokyo Medical University Hospital
Shinjuku-ku, Japan
9.08miles

Chikako Shimizu

National Center for Global Health and Medicine
Shinjuku-ku, Japan
9.7miles

Koichiro Tsugawa

St Marianna University School of Medicine Toyoko Hospital
Kawasaki, Japan
9.8miles

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.